Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review

Immunological differences between classical phenothypes of multiple sclerosis

(2015) Piotr Iwanowski et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Modelling the natural history of primary progressive multiple sclerosis

(2014) Katharine E Harding et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Composite end points to assess delay of disability progression by MS treatments

(2014) J Zhang et al.   Multiple Sclerosis Journal

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

(2014) J. Romme Christensen et al.   NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Employment among Patients with Multiple Sclerosis-A Population Study

(2014) Hanne Marie Bøe Lunde et al.   PLoS One

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride

(2013) Tarunya Arun et al.   BRAIN

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

(2013) John Zajicek et al.   LANCET NEUROLOGY

Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan

(2013) Richard A Rudick et al.   Multiple Sclerosis Journal

Cognitive impairment differs between primary progressive and relapsing-remitting MS

(2013) A. Ruet et al.   NEUROLOGY

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

(2012) Jack Antel et al.   ACTA NEUROPATHOLOGICA

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

(2012) Patrick Vermersch et al.   BMC Neurology

Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study

(2012) Mandana Mohyeddin Bonab et al.   Current Stem Cell Research & Therapy

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

(2011) J D Bowen et al.   BONE MARROW TRANSPLANTATION

Progressive Multiple Sclerosis: Characteristics and Management

(2011) Kathleen Hawker   NEUROLOGIC CLINICS

PAW25 A single-centre, pilot, randomised controlled trial of recombinant human erythropoietin in primary progressive multiple sclerosis

(2010) I. Karpha et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

(2009) H. Tremlett et al.   JOURNAL OF NEUROLOGY

Glatiramer acetate treatment in PPMS: Why males appear to respond favorably

(2009) Jerry S. Wolinsky et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

(2009) X. Montalban et al.   Multiple Sclerosis Journal

The natural history of primary progressive multiple sclerosis

(2009) M. Koch et al.   NEUROLOGY

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

(2008) Zhaleh Khaleeli et al.   ANNALS OF NEUROLOGY

MxA protein an interferon beta biomarker in primary progressive multiple sclerosis patients

(2008) A. Millonig et al.   EUROPEAN JOURNAL OF NEUROLOGY

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis

(2008) M Gironi et al.   Multiple Sclerosis Journal